ACR Convergence 2020 Archives - Page 99 of 139

Abstract Number: 1723

RA Flare Prediction via Machine Learning and Algorithm Based on SSDM Big Data
Abstract Number: 1702

RA-Related Knowledge and Skills of Rheumatology Fellows Among 20 US Academic Institutions
Abstract Number: 0843

Rab4A Activation Predisposes to Hepatitis in Spontaneous and Pristane-Induced Mouse Models of Systemic Lupus Erythematosus
Abstract Number: 0844

Rab4A Regulates Glomerulonephritis and Tryptophan Metabolism in Sle1.2.3. Lupus-prone Mice via Recycling of CD98
Abstract Number: 0006

Race/ethnicity Is Associated with Poor Health Outcomes Amongst Rheumatic Disease Patients Diagnosed with COVID-19 in the US: Data from the COVID-19 Global Rheumatology Alliance Physician-Reported Registry
Abstract Number: 0042

Racial and Ethnic Differences in a Multiple Biochemical Measure of Rheumatoid Arthritis Disease Activity
Abstract Number: 1017

Racial and Ethnic Disparities in the Risk of Preterm Birth Among Women with Systemic Lupus Erythematosus or Rheumatoid Arthritis with Varying Reference Groups
Abstract Number: 0055

Racial and Sex-based Disparities in Health Care Utilization: Eye Inflammation as a Paradigm
Abstract Number: 0433

Racial Disparities and New SLE-Specific Predictors of Stroke and Ischemic Heart Disease in Patients with Lupus
Abstract Number: 1644

Radiographic Exclusionary Findings During Screening for Three Phase III Trials of Subcutaneous Tanezumab in Patients with Moderate to Severe Hip or Knee Osteoarthritis
Abstract Number: 1231

Radiographic Outcomes in Patients with Rheumatoid Arthritis Receiving Upadacitinib as Monotherapy or in Combination with Methotrexate: Results at 2 Years
Abstract Number: 1895

Radiographic Progression in Patients with Axial Spondyloarthritis Under Treatment with TNF Inhibitors. Data from REGISPONSERBIO (Spanish Register of Biological Therapy in Spondyloarthritides)
Abstract Number: 1235

Radiographic Progression of Structural Joint Damage over 5 Years of Baricitinib Treatment in Patients with Rheumatoid Arthritis: Results from RA-BEYOND
Abstract Number: 1105

RANK-L Activity: Understanding the Pathogenesis of Erosive Osteoarthritis
Abstract Number: 1551

Rapid Effect of Tofacitinib in Reducing US Joint and Tendon Inflammatory Lesions of RA Patients: Data from a 24 Weeks Longitudinal Study
Abstract Number: 0458

Rapid Implementation of a Multidisciplinary COVID-19 Cytokine Storm Syndrome Task Force
Abstract Number: 1377

Raynaud’s Phenomenon and Systemic Sclerosis in Post-9/11 Deployed Veterans Receiving Care Veterans Health Administration Care
Abstract Number: 1253

Re-evaluation of the Extent of Lymphocytic Infiltration May Improve the Diagnostic Accuracy of Lip Biopsy in Primary Sjögren’s Syndrome (pSS)
Abstract Number: 1219

Reaching Remission by IL-1 Inhibition in Rheumatoid Arthritis Patients with Type 2 Diabetes Improves the Glucose Homeostasis: Long-term Findings from TRACK Study, a Multicentre, Open-label, Randomised, Controlled Trial
Abstract Number: 0651

Readmission Risk and Quality of Care in Patients Presenting to the Emergency Department with Gout Flares
Abstract Number: 1683

Ready or Not? Measuring Readiness for Transition to Adult Care in Adolescents with JIA & jSLE
Abstract Number: 0227

Real Life Severe Infections in Patients with Rheumatoid Arthritis on Treatment with Biological Therapy and JAK Inhibitors
Abstract Number: 1031

Real World Treatment Patterns Among Patients with Psoriatic Arthritis Treated with Ixekizumab
Abstract Number: 0802

Real-World DMARD Experience and Outcomes for Rheumatoid Arthritis Patients in Japan: Effectiveness
Abstract Number: 0803

Real-World DMARD Experience and Outcomes for Rheumatoid Arthritis Patients in Japan: Safety
Abstract Number: 1381

Real-World Mono-, Double and Triple Combination Treatment Patterns with Macitentan in Patients with Pulmonary Arterial Hypertension Associated with Connective Tissue Disease (PAH-CTD): Evidence from the Combined OPUS/OrPHeUS Dataset
Abstract Number: 0812

Real-World Utilization of Infliximab (IFX) and Its Biosimilars in Patients (Pts) with Rheumatoid Arthritis (RA) Since the First Biosimilar Approval in the US
Abstract Number: 0556

Recent Use, Missed Doses and Discontinuation of Infliximab in New-users: Comparisons of Biosimilar and Originator Exposures
Abstract Number: 0452

Recombinant Zoster Vaccine in Patients with Rheumatic Diseases: A Retrospective Study of 622 Patients
Abstract Number: 1088

Recruitment Rates of Virtual Remote Research (Tele-Research) in Myositis
Abstract Number: 1186

Red Cell Distribution Width and Absolute Lymphocyte Count Associate with Biomarkers of Inflammation and Subsequent Mortality in Rheumatoid Arthritis
Abstract Number: 1187

Red Cell Distribution Width Is Associated with ASCVD Risk Score and CVD in RA After Initiation of Methotrexate
Abstract Number: 1048

Reduced Decline in Forced Vital Capacity in Patients with Progressive Fibrosing Autoimmune Disease-Related Interstitial Lung Diseases (ILDs) Treated with Nintedanib
Abstract Number: 1425

Reduced Risk of Cardiovascular Diseases Events with Renal Transplantation in Granulomatosis with Polyangiitis in the United States: Data from the US Renal Data System
Abstract Number: 0456

Reduced Risk of Serious Pneumococcal Infection up to 10 Years After Immunization with 7-valent Conjugated Pneumococcal Vaccine in Patients with Inflammatory Arthritis
Abstract Number: 1965

Reducing Delays for Biologic Medication Approval in Outpatient Rheumatology
Abstract Number: 0952

Reducing Immunogenicity of Pegloticase (RECIPE) with Concomitant Use of Mycophenolate Mofetil in Patients with Refractory Gout—a Phase II Double Blind Randomized Controlled Trial
Abstract Number: 1227

Reduction in Peripheral CD19+ CD27- Naïve B Cells Is Associated with Clinical Remission in Patients with Rheumatoid Arthritis Receiving Combined Treatment with Methotrexate and TNF Inhibitors
Abstract Number: 0881

Reduction of Anterior Uveitis Flares in Patients with Axial Spondyloarthritis During Certolizumab Pegol Treatment: 96-Week Results from the C-VIEW Study
Abstract Number: 0187

Regional and Widespread Patterns of Non-articular Pain Are Common at RA Diagnosis and Contribute to Poor Outcomes at 12 Months: A Prospective Study of Pain Patterns in Canadians with RA
Abstract Number: 1489

Relation of Pain Mechanisms to Development of Knee Pain in Osteoarthritis: The Multicenter Osteoarthritis Study
Abstract Number: 0563

Relation of Pain Sensitization to Isokinetic Knee Extension Torque: The MOST Study
Abstract Number: 1037

Relationship Between Air Quality and Sarcoidosis Inflammatory Activity
Abstract Number: 1211

Relationship Between Changes in Lipid Levels and Improvement in Disease Activity Outcomes in Patients with Rheumatoid Arthritis Receiving Upadacitinib Treatment: Pooled Analysis of Data from Two Phase 3 Studies
Abstract Number: 1600

Relationship Between Electronic Health Record Vendor and Performance on Patient-reported Outcome Quality Measures in the ACR’s Rheumatology Informatics System for Effectiveness (RISE) Registry
Abstract Number: 0484

Relationship Between Paraoxonase-1 Genotype, Activity, and Major Adverse Cardiovascular Events in Patients with Rheumatoid Arthritis Receiving Tofacitinib
Abstract Number: 0491

Relationship Between Rheumatoid Arthritis and Pulmonary Function in the UK Biobank
Abstract Number: 1020

Relationship Between Skin-related Quality of Life, Psychosocial Stress, and Race in Cutaneous Lupus Erythematosus
Abstract Number: 1112

Relationship of Depth-Specific Subchondral Bone Mineral Density and Pain in Knee Osteoarthritis: The Multicenter Osteoarthritis Study
Abstract Number: 1337

Relationship of the Pro12Ala Polymorphism of the PPARg Gene with Inflammatory Activity, Osteoporosis and Obesity in Patients with Psoriatic Arthritis
Abstract Number: 0694

Relationships Among Adherence and Patient Outcomes in a Cognitive Behavioral Plus Physical Activity Intervention for Older Adults with Osteoarthritis and Hypertension
Abstract Number: 0158

Relationships Between Disease Patterns in RA and Rheumatology Treatment
Abstract Number: 1872

Relative Associations of Sociodemographic, Clinical and HLA-B Alleles with Enthesitis and Peripheral Arthritis in Patients with Ankylosing Spondylitis
Abstract Number: 0943

Reliability and Validity Issues in Fibromyalgia Diagnosis
Abstract Number: 1168

Reliability and Validity of a New Skin Activity Measure for Localized Scleroderma
Abstract Number: 1889

Reliability and Validity of the PROMIS-29 Health Profile in Ankylosing Spondylitis Patients
Abstract Number: 1132

Reliability of Virtual Sources of Education for Patients with Vasculitis
Abstract Number: 1375

Remission in Axial Spondyloarthritis: Is There a Difference Between NSAIDs and Biologics in the Real Life?
Abstract Number: 1710

Remote Rheumapalooza: Reboot of a Foundational Rheumatology Curriculum for Pre-Clinical Medical Students in the Era of Virtual Learning
Abstract Number: 1672

Renal Activity Index for Lupus Nephritis Distinguishes Active Renal Disease Among Childhood Systemic Lupus Erythematosus Patients
Abstract Number: 0686

Renal Evolution During the First Year of Urate-lowering Therapy According to Sonographic Joint Deposition: Data from the Lille-Alicante Inception Cohort
Abstract Number: 1515

Renal Responder Status and Associated Clinical Variables in the Lupus Accelerating Medicines Partnership Cohort
Abstract Number: 1791

Renal Tubular Complement C9 Deposition Is Associated with Renal Tubular Damage and Fibrosis in Lupus Nephritis
Abstract Number: 0965

Repetitive Inhalant Lipopolysaccharide Exposure in the Setting of Arthritis Induction Potentiates Pro-Fibrotic Inflammatory Lung Disease in Mice
Abstract Number: 1842

Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus: Post Hoc Analyses of Patient-Reported Outcomes from a Phase 4, Multicenter, Randomized, Double-blind, Placebo-Controlled Trial
Abstract Number: 0440

Representation of Women as Authors of Rheumatology Research Articles
Abstract Number: 1786

Reproductive Health Outcomes in Women with RA and PsA
Abstract Number: 2045

Resident Memory T Cells in Synovial Tissue Mediate Arthritis Flares
Abstract Number: 1410

Resident Memory T Cells Persist in Joints of Anakinra-Treated Mice in Spontaneous Arthritis Model
Abstract Number: 0909

Residual Disease Activity in Psoriatic Arthritis Patients Treated with Secukinumab and Adalimumab Who Achieved Remission or Low Disease Activity: Results from a Phase 3b, Randomized, Double-blinded, Active-controlled, Head-to-head Study
Abstract Number: 0323

Residual Symptoms in Patients with PsA Who Are in Very Low Disease Activity According to Physician Assessments
Abstract Number: 0863

Residual Treatment Burden, Desired Improvement, and Prioritized Treatment Goals in Systemic Lupus Erythematosus (SLE): Results from the SLE-UPDATE (Understanding Preferences, Disease Activity and Treatment Expectations) Survey in the United States
Abstract Number: 1407

Resolvin D5 Modulates Th17/Treg Cell Differentiation and Suppresses Osteoclastogenesis
Abstract Number: 2034

Resolving Phenotypic and Prognostic Differences in Interstitial Lung Disease Related to Systemic Sclerosis by Computed Tomography-based Radiomics
Abstract Number: 0714

Response to Abatacept in JIA Categories: Results from the PRCSG/PRINTO JIA Abatacept Phase IV Registry
Abstract Number: 0904

Response to Ixekizumab by C-reactive Protein Level in Patients with Radiographic Axial Spondyloarthritis: Results from the COAST-V (Biological-Naïve) and COAST-W (TNF Inhibitor-Experienced) Trials at 52 Weeks
Abstract Number: 1554

Response to Tocilizumab in Large Vessel Vasculitis According to the Extent of Baseline 18F-FDG Vascular Uptake
Abstract Number: 0361

Response to Treatment with Ixekizumab in Patients with Active Non-Radiographic Axial Spondyloarthritis Based on HLA-B27 Status and Disease Duration
Abstract Number: 0869

Retinal Toxicity in a Multinational Inception Cohort of Systemic Lupus Patients on Hydroxychloroquine
Abstract Number: 0078

Retrospective Analysis of Clinical Characteristics and Classification Criteria Performance in a Single Center Cohort of 114 Patients Diagnosed with IgG4-Related Disease
Abstract Number: 1141

Reversing Seasonal Decline of T2T Outcome in RA Patients Under Double Hits by Chinese New Year and COVID-19 Epidemic via Online Interaction with SSDM
Abstract Number: 0093

Review of Gastrointestinal Manifestations of Kohlmeier-Degos Disease
Abstract Number: 1586

Rheum Service: Comprehensive Virtual Care During COVID-19
Abstract Number: 1177

Rheumatic Diseases in Mexican Children and Their Psychosocial and Economic Impact on Caregivers
Abstract Number: 1759

Rheumatoid Arthritis Affects the Ossicular Joints: A Human Otopathologic Study
Abstract Number: 1994

Rheumatoid Arthritis Improvement After Exposure to an Anti-Inflammatory “ITIS” Diet Is Associated with Changes of Gut Microbiome and Systemic Metabolome
Abstract Number: 1761

Rheumatoid Arthritis Inpatient Mortality: An Analysis of the National Inpatient Sample
Abstract Number: 0167

Rheumatoid Arthritis Patient Phenotypes from a Digital Health Coaching Engagement Program
Abstract Number: 0567

Rheumatologist’s Perception of the Efficacy, Safety and Willingness to Prescribe Infliximab and Use Alternate Drug Supply Programs to Lower Cost of Rheumatoid Arthritis Care
Abstract Number: 0061

Rheumatologists’ Attitudes Toward Palliative Care and Medical Assistance in Dying
Abstract Number: 0477

Rheumatology Fellowship Program Directors in the United States: Analysis of Demographics, Educational and Scholarly Achievements
Abstract Number: 0615

Rheumatology Going Digital: Developing a Rheumatology App for Use by All Patients Attending Our Department to Aid Remote Working and Self-management
Abstract Number: 0636

Rheumatology Patient Experience and Trends During the SARS-COV-2 Pandemic
Abstract Number: 0788

Rigorous Plasma Microbiome Analysis Method Enables Disease Association Discovery
Abstract Number: 1046

Risk Factors Associated with Interstitial Lung Disease in Patients with RA: Findings from a Retrospective Healthcare Database Analysis
Abstract Number: 1694

Risk Factors Associated with Pneumocystis Jirovecii Pneumonia in Juvenile Myositis in North America
Abstract Number: 1324

Risk Factors for Adverse Pregnancy Outcomes in Women with Spondyloarthritis: An Observational Study from Two European Multidisciplinary Pregnancy Clinics
Abstract Number: 1775

Risk Factors for Adverse Pregnancy Outcomes of Women with Positive for Antiphospholipid Antibodies Treated with Conventional Therapies
Abstract Number: 1825

Risk Factors for Antimalarial-Induced Retinal Toxicity in Systemic Lupus Erythematosus and Other Rheumatic Diseases
Abstract Number: 1947

Risk Factors for Anxiety and Depression in Patients with Giant Cell Arteritis
Abstract Number: 0561

Risk Factors for Falls Among Individuals with Knee OA: A Longitudinal Community-based Study
Abstract Number: 0926

Risk Factors for Fractures and Osteoporosis Among Patients with Systemic Sclerosis in a United States Cohort
Abstract Number: 0544

Risk Factors for Lumbar Vertebral Osteoporosis Do Not Reflect Factors Traditionally Associated with Osteoporosis at the Hip
Abstract Number: 0670

Risk Factors for Pseudogout: An Electronic Medical Record Case-Control Study
Abstract Number: 0579

Risk Factors of Nonadherence in New Rheumatoid Arthritis Patients
Abstract Number: 1938

Risk for Vision Loss and Relapse in Patients with Giant Cell Arteritis
Abstract Number: L02

Risk Mitigating Behavior in People with Rheumatic Diseases or Psoriasis During the COVID-19 Pandemic Differ by Immunosuppressant Treatment Type: A Patient survey Study
Abstract Number: 0120

Risk of Fracture in Patients with Different Glucocorticoid Requiring Diseases
Abstract Number: 0540

Risk of Hydroxychloroquine Retinopathy in the Community
Abstract Number: 1001

Risk of Malignant Melanoma and Nonmelanoma Skin Cancer in Rheumatoid Arthritis Patients Initiating Methotrexate versus Hydroxychloroquine
Abstract Number: 1005

Risk of Non-vertebral Fractures Among Rheumatoid Arthritis Patients Treated with Biologic or Targeted-Synthetic DMARDs: A Multi-Database Comparative Safety Study
Abstract Number: 1417

Risk of Relapse of ANCA-associated Vasculitis in Patients of 75 Years and Older: A Retrospective Study
Abstract Number: 0580

Risk of Severe Acute Localized Reactions for Different Intra-Articular Hyaluronic Acid Knee Injections in a Real World Setting
Abstract Number: 2000

Risk of Venous Thromboembolism in Rheumatoid Arthritis Patients Treated with Methotrexate versus Hydroxychloroquine
Abstract Number: 0650

Risk of Vertebral Fractures at Lateral Chest Radiographies in Patients with Gout
Abstract Number: 1149

Risk Score of Macrophage Activation Syndrome (MAS) in Patients with Systemic Juvenile Idiopathic Arthritis (sJIA)
Abstract Number: 1051

Rituximab for Interstitial Pneumonia with Autoimmune Features at Two Academic Medical Centers
Abstract Number: 0527

Rituximab for Refractory Manifestations of the Antiphospholipid Syndrome: A Multicenter Israeli Experience
Abstract Number: 1578

Rituximab Hypersensitivity in Rheumatic and Inflammatory Diseases: Role of Skin Testing
Abstract Number: 1438

Rituximab Immunogenicity in ANCA-associated Vasculitis (RITUXIMAV)
Abstract Number: 1050

Rituximab in the Treatment of Interstitial Lung Disease Associated with Autoimmune Diseases: Experience from a Single Referral Center
Abstract Number: 0287

RNA Externalized by Neutrophil Extracellular Traps Promotes Inflammatory Pathways in Endothelial Cells
Abstract Number: 1547

Role of Artificial Intelligence in Assessment of Peripheral Joint MRI in Inflammatory Arthritis: A Systematic Review and Meta-analysis
Abstract Number: 0783

Role of Glutamine Metabolism in Rheumatoid Arthritis Fibroblast-Like Synoviocyte Aggressive Phenotype
Abstract Number: 0682

Role of Inflammatory and Oxidative Stress Pathway Biomarkers in Renal Disease in Gout
Abstract Number: 0974

Role of NR4A Nuclear Receptor Family in RA Synovial Ectopic Lymphoid Neogenesis Revealed by Single Cell Profiling
Abstract Number: 1513

Role of Platelet C4d in Thrombosis and Lupus Nephritis
Abstract Number: 0290

Role of Protein Tyrosine Phosphatase 1B (PTP1B) in Endothelial-to-Mesenchymal Transition (EndoMT) Promoted by Inflammation: Implications for SLE
Abstract Number: 0056

Role of Socioeconomic and Cultural Factors in Racial Disparities in Disease Severity and Health Status of Patients with Axial Spondyloarthritis
Abstract Number: 1784

Roles and Perspectives of Partners of Women with Rheumatoid Arthritis on Reproductive Decision Making: A Constructivist Grounded Theory Study
Abstract Number: 0101

Romosozumab After Denosumab Improves Lumbar Spine and Maintains Total Hip Bone Mineral Density in Postmenopausal Women with Low Bone Mass
Abstract Number: 0139

Routine Assessment of Patient Index Data (RAPID) 3 as a Predictor of Weight Reduction in Rheumatology Patients Undergoing Bariatric Surgery